MYT NETHERLANDS PARENT BV (MYTE) Stock Fundamental Analysis
NYSE:MYTE - New York Stock Exchange, Inc. - US55406W1036 - ADR - Currency: USD
Overall MYTE gets a fundamental rating of 3 out of 10. We evaluated MYTE against 121 industry peers in the Specialty Retail industry. The financial health of MYTE is average, but there are quite some concerns on its profitability. MYTE is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year MYTE was profitable.
MYTE had a negative operating cash flow in the past year.
MYTE had negative earnings in 4 of the past 5 years.
In multiple years MYTE reported negative operating cash flow during the last 5 years.
1.2 Ratios
MYTE's Return On Assets of -5.01% is on the low side compared to the rest of the industry. MYTE is outperformed by 68.85% of its industry peers.
MYTE's Return On Equity of -8.64% is in line compared to the rest of the industry. MYTE outperforms 42.62% of its industry peers.
MYTE's Return On Invested Capital of 0.05% is on the low side compared to the rest of the industry. MYTE is outperformed by 63.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.01% | ||
| ROE | -8.64% | ||
| ROIC | 0.05% |
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
MYTE has a worse Operating Margin (0.03%) than 63.93% of its industry peers.
With a decent Gross Margin value of 47.04%, MYTE is doing good in the industry, outperforming 72.13% of the companies in the same industry.
In the last couple of years the Gross Margin of MYTE has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.03% | ||
| PM (TTM) | N/A | ||
| GM | 47.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MYTE is destroying value.
The number of shares outstanding for MYTE has been increased compared to 1 year ago.
Compared to 5 years ago, MYTE has less shares outstanding
MYTE has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.23 indicates that MYTE is not in any danger for bankruptcy at the moment.
MYTE has a Altman-Z score of 4.23. This is amongst the best in the industry. MYTE outperforms 86.07% of its industry peers.
A Debt/Equity ratio of 0.19 indicates that MYTE is not too dependend on debt financing.
MYTE has a better Debt to Equity ratio (0.19) than 61.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.23 |
ROIC/WACC0.01
WACC7.41%
2.3 Liquidity
MYTE has a Current Ratio of 1.78. This is a normal value and indicates that MYTE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.78, MYTE is in the better half of the industry, outperforming 76.23% of the companies in the same industry.
A Quick Ratio of 0.22 indicates that MYTE may have some problems paying its short term obligations.
The Quick ratio of MYTE (0.22) is worse than 85.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.78 | ||
| Quick Ratio | 0.22 |
3. Growth
3.1 Past
MYTE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 525.00%, which is quite impressive.
MYTE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.84%.
Measured over the past years, MYTE shows a quite strong growth in Revenue. The Revenue has been growing by 17.27% on average per year.
EPS 1Y (TTM)525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)11.84%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%13.17%
3.2 Future
MYTE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.63% yearly.
Based on estimates for the next years, MYTE will show a quite strong growth in Revenue. The Revenue will grow by 9.58% on average per year.
EPS Next Y291%
EPS Next 2Y115.23%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue Next Year9.06%
Revenue Next 2Y9.71%
Revenue Next 3Y9.58%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 27.29, MYTE can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as MYTE.
MYTE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.30.
MYTE is valuated rather expensively with a Price/Forward Earnings ratio of 18.32.
Based on the Price/Forward Earnings ratio, MYTE is valued a bit cheaper than the industry average as 61.48% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.76. MYTE is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.29 | ||
| Fwd PE | 18.32 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MYTE indicates a slightly more expensive valuation: MYTE is more expensive than 67.21% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 49.69 |
4.3 Compensation for Growth
MYTE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MYTE's earnings are expected to grow with 54.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y115.23%
EPS Next 3Y54.63%
5. Dividend
5.1 Amount
MYTE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:MYTE (4/30/2025, 8:23:38 PM)
7.64
-0.2 (-2.55%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.04B
Analysts76.36
Price Target10.71 (40.18%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.51%
Min EPS beat(2)96.08%
Max EPS beat(2)206.95%
EPS beat(4)2
Avg EPS beat(4)50.27%
Min EPS beat(4)-50.98%
Max EPS beat(4)206.95%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.32%
Min Revenue beat(2)-3.03%
Max Revenue beat(2)0.39%
Revenue beat(4)1
Avg Revenue beat(4)-1.89%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)0.39%
Revenue beat(8)3
Avg Revenue beat(8)-0.99%
Revenue beat(12)4
Avg Revenue beat(12)-1.89%
Revenue beat(16)7
Avg Revenue beat(16)-0.73%
PT rev (1m)0%
PT rev (3m)49.57%
EPS NQ rev (1m)-140.01%
EPS NQ rev (3m)-111.77%
EPS NY rev (1m)0%
EPS NY rev (3m)17.95%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.97%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.29 | ||
| Fwd PE | 18.32 | ||
| P/S | 1.05 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.23 | ||
| P/tB | 3.57 | ||
| EV/EBITDA | 49.69 |
EPS(TTM)0.28
EY3.66%
EPS(NY)0.42
Fwd EY5.46%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS7.27
BVpS3.42
TBVpS2.14
PEG (NY)0.09
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.01% | ||
| ROE | -8.64% | ||
| ROCE | 0.06% | ||
| ROIC | 0.05% | ||
| ROICexc | 0.05% | ||
| ROICexgc | 0.07% | ||
| OM | 0.03% | ||
| PM (TTM) | N/A | ||
| GM | 47.04% | ||
| FCFM | N/A |
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
F-Score3
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.11 | ||
| Cap/Depr | 47.13% | ||
| Cap/Sales | 1.02% | ||
| Interest Coverage | 0.05 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.78 | ||
| Quick Ratio | 0.22 | ||
| Altman-Z | 4.23 |
F-Score3
WACC7.41%
ROIC/WACC0.01
Cap/Depr(3y)134.72%
Cap/Depr(5y)94.09%
Cap/Sales(3y)2.03%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y291%
EPS Next 2Y115.23%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue 1Y (TTM)11.84%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%13.17%
Revenue Next Year9.06%
Revenue Next 2Y9.71%
Revenue Next 3Y9.58%
Revenue Next 5YN/A
EBIT growth 1Y101.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year188.35%
EBIT Next 3Y67.88%
EBIT Next 5YN/A
FCF growth 1Y18.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-407.95%
OCF growth 3YN/A
OCF growth 5Y33.41%